Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

The Bastide Group enters the respiratory care devices market in Italy


Caissargues, July 18, 2022

The Bastide Group announces the acquisition of a majority stake in Oxystore, a company based near Milan, Italy. Oxystore specializes in home diagnosis and online sales of oxygen therapy and sleep apnea equipment for consumers. It also offers support and follow-up services to patients undergoing therapy at home.

In 2021, the company generated revenues of €4.1 million with an operating margin that was above Group standards. Oxystore is mainly present in Italy as well as in Switzerland and Spain, where it will complement the range of products offered by the Group's subsidiaries already present in these countries.

Oxystore's integration into the Bastide Group will allow it to improve the efficiency of its supply chain and benefit from better purchasing conditions, accelerating its expansion in Europe. With this transaction, the Bastide Group is expanding into Italy, a country with considerable demographic potential, thereby extending its geographical footprint in Europe. By positioning itself in a segment directly financed by patients or by their complementary health insurance, the Group is also pursuing its regulatory risk reduction strategy.

The acquisition will be paid in cash including deferred components and will ensure a long-term presence for Oxystore's founder. Oxystore will be consolidated within the Group's financial statements with effect from July 1, 2022.

 

NEXT MEETING:

2021-2022 revenue on Wednesday August 31, after the close of trading

 


About Groupe Bastide Le Confort Médical

Created in 1977 by Guy Bastide, Groupe Bastide is a leading European provider of home healthcare services. Present in 6 countries, Bastide develops a permanent quality approach and is committed to providing medical devices and associated services that best meet patients' needs in key health areas: diabetes, nutrition, infusion, respiratory care, stomatherapy and urology. Bastide is listed on Euronext Paris (ISIN: FR0000035370, Reuters BATD.PA, - Bloomberg BLC: FP)

 

 

Groupe Bastide Actus Finance  
 
Vincent Bastide/Olivier Jourdanney
T. +33 (0)4 66 38 68 08
www.bastide-groupe.fr
 
Analyst-Investor
Hélène de Watteville
T. +33 (0)1 53 67 36 33 
 
Press – Media
Déborah Schwartz
T. +33 (0)1 53 67 36 35


This publication embed "🔒 Actusnews SECURITY MASTER".
- SECURITY MASTER Key: mWtylsqZZpnHnptsk8ZsaGZsm5yXkpPGa2rIlGhpaszImm6VmpmSmJeWZnBmmmlr
- Check this key: https://www.security-master-key.com.



Regulated information:
Inside Information:
- Operations of the issuer (acquisitions, sales…)


Full and original press release in PDF: https://www.actusnews.com/news/75545-oxystore_eng.pdf

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free

Source Actusnews

Bastide Le Confort Stock

€16.68
0.600%
The Bastide Le Confort stock is trending slightly upwards today, with an increase of €0.10 (0.600%) compared to yesterday's price.

Like: 0
Share

Comments